rs786204815
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_014795.4(ZEB2):c.1027C>T(p.Arg343*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_014795.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461596Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727026
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mowat-Wilson syndrome Pathogenic:7
- -
- -
- -
Variant summary: ZEB2 c.1027C>T (p.Arg343X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been reported in affected individuals (HGMD). The variant was absent in 251184 control chromosomes (gnomAD). c.1027C>T has been reported in the literature in multiple individuals affected with Mowat-Wilson Syndrome (examples: Wilson_2003, Ishihara_2004, Yamada_2014, Schuster_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five ClinVar submitters have assessed this variant after 2014, and all submissions have classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This sequence change creates a premature translational stop signal (p.Arg343*) in the ZEB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ZEB2 are known to be pathogenic (PMID: 16053902). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Mowat-Wilson syndrome (PMID: 12784289, 15121779, 19842203, 24715670). ClinVar contains an entry for this variant (Variation ID: 189281). For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 25525159, 12784289, 31376723, 15384097, 19842203, 24715670, 25608121, 25899569, 16053902) -
- -
Inborn genetic diseases Pathogenic:1
The c.1027C>T (p.R343*) alteration, located in exon 8 (coding exon 7) of the ZEB2 gene, consists of a C to T substitution at nucleotide position 1027. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 343. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD), the ZEB2 c.1027C>T alteration was not observed, with coverage at this position. This alteration has been detected in several individuals with symptoms consistent with Mowat Wilson syndrome (Wilson, 2003; Zweier, 2005; Yamada, 2014; Paz, 2015). An 18 year old male reported by Wilson et al. (2003) had intellectual disability, epilepsy, microcephaly, tetralogy of Fallot, hypospadias, and pelvi-ureteric junction obstruction._x000D_ _x000D_ reminder to manually add internal co-seg data to report Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at